ClinVar Miner

Submissions for variant NM_000019.4(ACAT1):c.578T>C (p.Met193Thr)

dbSNP: rs541517496
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Department of Pediatrics, Gifu University RCV000844794 SCV000966067 likely pathogenic Deficiency of acetyl-CoA acetyltransferase 2019-05-05 criteria provided, single submitter research
Labcorp Genetics (formerly Invitae), Labcorp RCV000844794 SCV001401847 pathogenic Deficiency of acetyl-CoA acetyltransferase 2021-08-26 criteria provided, single submitter clinical testing This sequence change replaces methionine with threonine at codon 193 of the ACAT1 protein (p.Met193Thr). The methionine residue is highly conserved and there is a moderate physicochemical difference between methionine and threonine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individual(s) with mitochondrial acetoacetyl-CoA thiolase deficiency (PMID: 15877211, 20046049). It has also been observed to segregate with disease in related individuals. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects ACAT1 function (PMID: 15877211). This variant disrupts the p.Met193 amino acid residue in ACAT1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23958592, 27928777). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Neuberg Centre For Genomic Medicine, NCGM RCV000844794 SCV004046990 pathogenic Deficiency of acetyl-CoA acetyltransferase criteria provided, single submitter clinical testing The missense c.578T>Cp.Met193Thr variant in ACAT1 gene has been reported previously in compound heterozygous state in individuals affected with mitochondrial acetoacetyl-CoA thiolase deficiency Thümmler S et al., 2010. Experimental studies have shown that this missense change affects ACAT1 function Mrázová L et al., 2005. This variant is reported with the allele frequency of 0.0004% in the gnomAD Exomes and novel in 1000 Genomes. This variant has been reported to the ClinVar database as Likely Pathogenic / Pathogenic. The amino acid Met at position 193 is changed to a Thr changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Met193Thr in ACAT1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The variant is predicted as damaging by SIFT. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.